Discovery of Imidazo[1,2-<i>b</i>]pyridazine Derivatives: Selective and Orally Available Mps1 (TTK) Kinase Inhibitors Exhibiting Remarkable Antiproliferative ActivityKen‐ichi Kusakabe, Yusuke Nakamura, Takahiko Yamamoto et al.|Journal of Medicinal Chemistry|2015Cited by 64
Indazole-Based Potent and Cell-Active Mps1 Kinase Inhibitors: Rational Design from Pan-Kinase Inhibitor Anthrapyrazolone (SP600125)Ken‐ichi Kusakabe, Yusuke Nakamura, Nobuyuki Ide et al.|Journal of Medicinal Chemistry|2013Cited by 47